Hospital Variation In The Use Of High Intensity Healthcare Resources And Its Association With Patient Outcomes by Safavi, Kyan
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library School of Medicine
January 2013
Hospital Variation In The Use Of High Intensity
Healthcare Resources And Its Association With
Patient Outcomes
Kyan Safavi
Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Safavi, Kyan, "Hospital Variation In The Use Of High Intensity Healthcare Resources And Its Association With Patient Outcomes"






Hospital variation in the use of high intensity healthcare resources and its 
association with patient outcomes 
 
 
A Thesis Submitted to the Yale University School of Medicine in Partial Fulfillment of 
the Requirements for the Degree of Doctor of Medicine 
 
By 











Without any of the individuals mentioned here, none of this work or the joy 
of doing it would be possible. First and foremost, I would like to thank Dr. Harlan M. 
Krumholz for giving me incredibly rich mentorship and passionate inspiration while 
being fantastically busy doing the hard work to reform our healthcare system. I 
would also like to thank my mentors who I worked shoulder-to-shoulder with on 
these projects and who provided powerful guidance: Kumar Dharmarajan, Nancy 
Kim, Arjun K. Venkatesh, and Tara Lagu. The methodological and analytical support 
from Kelly M. Strait and Shu-Xia Li was quintessential and I am very lucky that they 
are both extremely kind and patient individuals. I would also like to thank Serene I. 
Chen, a fellow medical student, for working together with me to uncover out initial 
research questions. A special thank you to Premier Inc. for creating the database 
that we used in these studies and for making them available for academic research, 
as well as all of the grant funders who made this research possible, including: the 
Patrick and Catherine Weldon Donaghue Medical Research Foundation, the National 
Center for Advancing Translational Sciences, and the National Heart, Lung, and 







TABLE OF CONTENTS 
Introduction ................................................................................................ 4 
Chapter 1 .................................................................................................... 7 
1.1 Abstract ............................................................................................. 8 
1.2 Introduction ..................................................................................... 10 
1.3 Methods .......................................................................................... 11 
1.4 Results ............................................................................................ 15 
1.5 Discussion........................................................................................ 18 
1.6 Tables and figures ............................................................................. 24 
 
Chapter 2 .................................................................................................. 39 
2.1 Abstract ........................................................................................... 40 
2.2 Introduction ..................................................................................... 42 
2.3 Methods .......................................................................................... 44 
2.4 Results ............................................................................................ 49 
2.5 Discussion........................................................................................ 52 
2.6 Tables and figures ............................................................................. 58 
 
Conclusions ............................................................................................... 68 







Hospitals exert significant influence on the quality of care that patients 
receive, even after controlling for patient-level differences. Substantial variation 
exists among U.S. hospitals in terms of patient mortality rates at 30 days after 
admission for acute myocardial infarction (AMI), heart failure (HF), and stroke.1-3 
These results persist after adjustment for patient-level clinical risk factors and 
demographics, including co-morbidities, age, and gender. Risk-adjusted 
readmission rates demonstrate even more dramatic variation across hospitals. In 
addition to differences in their performance on outcomes, hospitals have 
demonstrated a varying ability to follow guideline-based processes of care in the 
treatment of some of the most common conditions that require in-patient hospital 
admission, including HF and AMI.4, 5  
The hospital is becoming a focal point in the effort to increase quality in the 
healthcare system. The federal government has recognized that engaging hospitals 
in quality improvement initiatives may make a significant impact in patient care 
across the United States. The Center for Medicare and Medicaid Services (CMS) now 
penalizes hospitals with a reduction in reimbursement rates if they do not report 
their performance on a wide range of quality measures, which are then publically 
reported on CMS’ Hospital Compare website.6 Beginning in 2013, CMS will go 
further by reducing reimbursements to hospitals if they do not meet certain 
performance benchmarks.7 In order to meet goals of quality improvement, studies 
are attempting to identify and characterize clinical practice patterns at the hospital 
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level in order to determine whether they are associated with better or worse patient 
outcomes.  
Beyond quality, hospital practice patterns deeply affect the healthcare 
system because they have enormous cost implications, as hospitals account for a 
disproportionately large percentage of healthcare costs in the U.S. In 2010, almost 
one-third of overall healthcare spending occurred because of hospitals.8 Yet there is 
no clear relationship between hospital cost and the quality of care delivered to the 
patient, such that higher cost care does not necessarily translate into better quality 
care. The unclear association between cost and quality has been demonstrated in a 
number of common and diverse diagnoses, ranging from sepsis to trauma.9-12 In a 
healthcare system facing increasingly limited resources, providers, payors, and 
policy makers are seeking to increase the value of care delivered to patients by 
identifying expensive, resource-intensive hospital practice patterns that are not 
associated with improved outcomes for the patient. Once practice patterns that 
increase cost but do not improve quality have been identified reform efforts have 
been directed to the hospital level successfully in the past.13-18 
Yet we remain ignorant of which hospital care patterns are useful versus 
wasteful. Thus, we sought to illustrate practice patterns across a large, diverse 
sample of U.S. hospitals in areas of care that are expensive, resource intensive, 
and potentially impactful on patient outcomes. We then sought to determine 
whether these distinct patterns of hospital care were associated with improved 
patient outcomes. What follows are two studies that examine this question.  The 
first study characterizes hospital admission practices to the ICU for patients 
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admitted with heart failure and their association with risk-standardized in-hospital 
mortality rates. The second study describes patterns of hospital utilization of 
myocardial imaging for patients presenting with suspected ischemia and their 
association with downstream resource use and readmission outcomes. We hope 
that our findings may serve as a basis for healthcare reform to engage hospitals in 


















Variation exists in rates of admission to intensive care units for heart failure 


















Background. Despite increasing attention on reducing relatively costly hospital 
practices while maintaining the quality of care, few studies have examined how 
hospitals use the intensive care unit (ICU), a high-cost setting, for patients 
admitted with heart failure (HF). We characterized hospital patterns of ICU 
admission for patients with HF and determined their association with the use of 
ICU-level therapies and patient outcomes.  
Methods and Results. We identified 166,224 HF discharges from 341 hospitals in 
the 2009-10 Premier Perspective® database. We excluded hospitals with <25 HF 
admissions, patients <18 years old, and transfers. We defined ICU as including 
medical ICU, coronary ICU, and surgical ICU. We calculated the percent of patients 
admitted directly to an ICU. We compared hospitals in the top-quartile (high ICU 
admission) with the remaining quartiles. The median percentage of ICU admission 
was 10% (Interquartile Range 6% to 16%; range 0% to 88%). In top-quartile 
hospitals, treatments requiring an ICU were used less often: percentage of ICU 
days receiving mechanical ventilation (6% top quartile versus 15% others), non-
invasive positive pressure ventilation (8% versus 19%), vasopressors and/or 
inotropes (9% versus 16%), vasodilators (6% versus 12%), and any of these 
interventions (26% versus 51%). Overall HF in-hospital risk standardized mortality 
was similar (3.4% versus 3.5%; P = 0.2). 
Conclusion. ICU admission rates for HF varied markedly across hospitals and 
lacked association with in-hospital risk-standardized mortality. Greater ICU use 
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correlated with fewer patients receiving ICU interventions. Judicious ICU use could 
reduce resource consumption without diminishing patient outcomes. 




One in 5 patients hospitalized with heart failure (HF) in the U.S. is admitted 
to an intensive care unit (ICU), a resource-intense setting that accounts for 20-35% 
of total hospital costs.19-21 Despite the high cost of ICU admission, there are no 
standard, evidence-based guidelines for ICU triage of patients with HF.22 The 
decision to admit patients to an ICU, therefore, may be a result of multiple factors, 
including the patients’ clinical status, practitioner discretion, institutional policies 
and procedures, and hospital capacity.23 Several patient-level studies conducted 
more than a decade ago demonstrated that patients are frequently admitted to the 
ICU who never receive ICU-level therapies during their hospitalization.24, 25 
However, we lack information about contemporary practice for patients with heart 
failure and hospital-level variation. 
The primary aim of this study is to describe patterns of ICU use for patients 
with HF among a diverse group of U.S. hospitals. Once we observed the variation in 
the use of ICUs, we compared groups of hospitals with distinct patterns of ICU use 
in terms of their management of HF within the ICU. We hypothesized that hospitals 
that more frequently triage patients with HF to the ICU admit, on average, lower-
risk patients to the ICU and therefore provide fewer ICU-level therapies and have 
lower risk-adjusted mortality rates for these patients compared with hospitals that 
have lower rates of ICU triage. Because we did not expect higher ICU triage to be 
associated with better patient outcomes, we expected that overall in-hospital risk-
standardized mortality rates (RSMRs) for all patients with HF would be similar 





Data Source  
We conducted a cross-sectional study using data from Perspective®, a 
voluntary, fee-supported database developed by Premier, Inc. for measuring quality 
and healthcare utilization. Premier is a private consortium of hospitals that pools 
finances and a limited set of clinical data from hundreds of U.S. hospitals into a 
common database.26 As of 2010, Perspective® contained data from more than 130 
million cumulative hospital discharges. These inpatient discharges represent about 
20% of all acute care inpatient hospitalizations nationwide. In addition to the 
information available in the standard hospital discharge file, Perspective® contains a 
date-stamped log of all billed items at the individual patient level including 
medications and laboratory, diagnostic, and therapeutic services, as well as limited 
clinical data about each patient. For this study, patient data were de-identified in 
accordance with the Health Insurance Portability and Accountability Act and a 
random hospital identifier assigned by Premier was used to identify the hospitals. 
The Yale University Human Investigation Committee reviewed the protocol for this 
study and determined that it is not considered to be Human Subjects Research as 
defined by the Office of Human Research Protections. 
Study Cohort 
We included hospitalizations from January 1, 2009 to December 31, 2010. To 
qualify for inclusion in the study cohort, patients must have had a principal 
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discharge diagnosis of HF (International Classification of Diseases, Ninth Revision, 
Clinical Modification (ICD-9-CM) code 402.01, 402.11, 402.91, 404.01, 404.03, 
404.11, 404.13, 404.91, 404.93, 428.xx).27 This code captures the reason, in 
retrospect, for the admission and is determined after discharge. Patients could 
contribute more than 1 hospitalization to the study cohort. Only hospitals that 
participated in Premier’s research program in 2009-2010 and had at least 25 cases 
of HF during that period were considered for inclusion in the study. Hospitalizations 
were excluded if patients were less than 18 years of age at the time of admission, 
assigned a pediatrician as the attending of record, transferred in from another 
hospital, or received cardiac surgery during their stay. Excluded cardiac surgeries 
were coronary artery bypass grafting, valvular surgery, peripheral vascular surgery, 
ventricular assist device placement, and heart transplantation.  
Outcomes 
We first conducted an exploratory analysis on the variation in admission 
rates to the ICU across hospitals within our cohort. The primary outcome for each 
hospital was the proportion of its HF hospitalizations that were admitted to an ICU. 
Admission to an ICU was defined as having a room and board charge for an ICU 
bed on the first day of the hospitalization. ICU beds included those located in the 
medical ICU, coronary care unit, or surgical ICU.  
We calculated the use of ICU-level therapies among patients with HF 
admitted to the ICU. ICU-level therapies were defined as commonly used therapies 
for acute decompensated HF typically only available in a critical-care setting. These 
included mechanical ventilation, intravenous (IV) vasopressors, IV inotropes, IV 
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vasodilators, intra-aortic balloon pumps (IABPs), and/or pulmonary artery 
catheters. We also measured the use of non-invasive positive pressure ventilation 
(NPPV), including continuous positive airway pressure and bi-level positive airway 
pressure, which requires an ICU setting in many institutions.  
We compared hospitals in terms of in-hospital all-cause mortality for patients 
with HF triaged to an ICU. Finally, we compared hospitals by in-hospital all-cause 
RSMRs for all patients admitted to the hospital with HF. 
Statistical Analysis 
Hospitals were divided into quartiles based on the proportion of patients 
admitted to the ICU, with the top quartile having the highest admission rates. The 
bottom 3 quartiles of hospitals had similar rates of ICU admission while the top-
quartile hospitals had distinctly higher rates of ICU admission. Thus, we defined the 
top quartile as a group of hospitals with high ICU admission rates and compared 
them with the rest of the hospitals in our cohort (hospitals in the bottom 3 
quartiles) for the remainder of the analysis. Hospital characteristics for the top 
quartile of hospitals were compared with the hospital characteristics for all other 
hospitals using chi-square tests to assess statistical differences. The top quartile of 
hospitals was compared with all other hospitals using chi-square tests to assess 
statistical differences for ICU-level therapies and ICU in-hospital mortality. A p-
value <0.05 was considered statistically significant in all cases. Continuous 
variables are reported with medians and interquartile ranges (IQR). 
Next, we calculated the proportion of days in the ICU in which the patient 
received mechanical ventilation, NPPV, IV vasopressors, IV inotropes, and/or IV 
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vasodilator drugs. Among all hospitalizations occurring at hospitals in the top 
quartile of ICU admission rates, we calculated the proportion of days that each 
therapy was given and compared this to the average among all hospitalizations 
occurring at other hospitals. Similarly, we calculated the frequency with which 
pulmonary artery catheters and IABPs were administered during each 
hospitalization and compared the frequency across all hospitalizations occurring at 
top-quartile hospitals versus other hospitals. The proportion of days without any 
intervention (mechanical ventilation, NPPV, vasopressors and/or inotropes, 
vasodilators, pulmonary artery catheters, IABP and dialysis) was also calculated 
and compared between top-quartile hospitals and other hospitals.  
In addition, we calculated the in-hospital all-cause mortality rate for patients 
triaged to top-quartile hospitals and compared it with the in-hospital all-cause 
mortality rate at other hospitals. We calculated RSMRs for each hospital using a 
hierarchical logistic regression, employing methods that are used in the outcomes 
measures that are publicly reported by the Centers for Medicare & Medicaid 
Services.28-32 Adjustment was done for patient characteristics including age, gender 
and Elixhauser comorbidities (Supplemental Table 1) classified using the software 
(version 3.4, 3.5, and 3.6 for Federal fiscal years 2009, 2010, and 2011, 
respectively) provided by the Healthcare Costs and Utilization Project of the Agency 
for Healthcare Research and Quality.33 The RSMRs for top-quartile hospitals were 
compared with RSMRs for the other hospitals using a Wilcoxon Rank Sum test. A p-
value <0.05 was considered statistically significant. All analyses were conducted 
with SAS version 9.2 (SAS Institute Inc., Cary, NC). Procedure GLIMMIX was used 
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to estimate the hierarchical logistic models. The figure was generated using R (R 
Development Core Team, Vienna, Austria).34 
 
1.4 Results 
Hospital Characteristics  
Our cohort included 166,224 patients treated at 341 hospitals from across 
the U.S. Of these, 19,169 patients were admitted directly to the ICU and accrued a 
total of 59,709 ICU days. The median hospital bed size was 265 (131, 402), volume 
of patients with HF was 407 (193, 709), and volume of patients with HF admitted to 
the ICU was 34 (20, 69). Hospitals tended to be located in the South (41%), serve 
an urban population (78%), and identify as non-teaching (72%; Table 1). Hospitals 
in the top-quartile of ICU admission rates and those in other quartiles tended to 
have similar characteristics in terms of geographic location and population served; 
however, they varied in terms of bed size (p<0.0001), ICU HF volume (p<0.0001), 
and teaching status (p=0.0108) (Table 1). We observed that hospitals in the 
bottom 3 quartiles were slightly larger (31% had more than 400 beds), had a lower 
number of ICU HF patients during the study period, and more teaching hospitals 
(32% vs. 17%).  In addition, we examined hospital characteristics within each of 
the 4 quartiles of ICU admission rates (Supplemental Table 2). We observed similar 
trends across the four quartiles with hospitals that have higher ICU admission rates 




ICU Admission Rates 
Of the 341 hospitals we analyzed, 328 admitted patients with HF directly to 
an ICU during the study period. Figure 1 shows the ICU admission rate for each of 
the 328 hospitals, ranked from lowest rate of admission to highest. The range of 
ICU admission rates was from 0% to 88% (median 10%, IQR: 6, 16%). Among 
hospitalizations at hospitals in the top quartile of ICU admissions, 32% of patients 
on average were admitted directly to the ICU compared with only 8% of patients at 
hospitals in the other quartiles (p<0.0001). Supplemental Figure 1 demonstrates 
the number of hospitals with the indicated ICU admission rates.  
ICU-Level Therapy Use 
We compared the percentage of ICU days in which patients received critical 
care interventions between top-quartile hospitals and other hospitals (Table 2). 
Patients at top-quartile hospitals spent less than half as many ICU days on 
mechanical ventilation compared with other hospitals (6% versus 15%, p<0.0001). 
Similarly, vasopressors and/or inotropes, vasodilators and NPPV were administered 
during a smaller percentage of ICU days at top-quartile hospitals versus other 
hospitals (9% versus 16% for vasopressors and/or inotropes, p<0.0001, 6% versus 
12% for vasodilators, p<0.0001, and 8% versus 19% for NPPV, p<0.0001). 
Overall, top-quartile hospitals had a lower percentage of ICU days in which any 
intervention was administered (26% versus 51%, p<0.0001). In addition, we 
observed similar trends when comparing all 4 quartiles of hospitals with higher 
admission quartiles having a lower percentage of ICU days in which patients 
received critical care interventions (Supplemental Table 3).     
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Furthermore, the proportion of patients receiving critical care interventions 
was compared between hospitals in the top quartile of ICU admission and other 
hospitals (Table 3). The proportion of patients receiving mechanical ventilation (7% 
versus 14%), NPPV (14% versus 31%), vasopressors and/or inotropes (9% versus 
18%), vasodilators (16% versus 25%), IABP (0.2% versus 0.5%), and dialysis 
(0.01% versus 0.1%) was lower at top-quartile hospitals compared with other 
hospitals (p<0.0001, p<0.0001, p<0.0001, p<0.0001, p=0.0016, and p=0.0139, 
respectively). The difference among hospital groups in the proportion of patients 
receiving pulmonary artery catheters was not statistically significant. We also 
compared all 4 quartiles of hospitals in terms of the proportion of patients receiving 
critical care interventions and observed similar trends (Supplemental Table 4). 
Mortality 
The in-hospital mortality rate for patients with HF triaged to the ICU at top-
quartile hospitals was 4% compared with 8% at other hospitals (Table 4). The 
overall RSMR for all patients with HF was not significantly different between top-
quartile and other hospitals (3.4% versus 3.5%, p-value 0.2; Table 4). The median 
length of stay for patients with HF was 4 days at top-quartile as well as at all other 
hospitals. In addition, we compared all 4 quartiles of hospitals in terms of the in-
hospital mortality rate for patients with HF triaged to the ICU and the overall RSMR 
for all patients with HF. Similarly, quartiles with higher admission rates had lower 
in-hospital ICU mortality and similar RSMR for all patients admitted with HF 
(Supplemental Table 5). 
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When comparing larger hospitals (>265 beds) with each other and smaller 
hospitals (<265 beds) with each other in terms of ICU admission rate, we found 
similar trends as in the primary analysis. Higher ICU admission hospitals had fewer 
ICU-level interventions, lower ICU mortality, and similar RSMRs compared with 
lower ICU admission hospitals.    
 
1.5 Discussion 
 In a large study of more than 300 hospitals in the U.S., we observed 
remarkable variation in the rates at which the hospitals triage patients with HF to 
the ICU. This variation in the rate of ICU admission was accompanied by variation 
in the use of ICU-level therapies for acute decompensated HF, such as mechanical 
ventilation and IV vasopressors and inotropic medications. Patients triaged to the 
ICU at hospitals that admitted a high percentage of patients with HF to the ICU 
were less likely to have these treatments compared with those admitted to 
hospitals with lower rates of ICU admission. This finding suggests that the former 
may be admitting relatively healthier patients to their ICUs. Consistent with this 
hypothesis, we found that patients with HF triaged to the ICUs of hospitals with 
high rates of ICU admission had lower mortality compared with patients with HF in 
the ICUs of hospitals that less frequently triaged to the ICU. While it is plausible 
that closer monitoring in the ICU without any HF-related critical care intervention 
may reduce ICU mortality, our data showed that overall in-hospital RSMRs for all 
patients admitted with HF did not differ by ICU admission patterns. Thus, hospitals 
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that most frequently triage patients with HF to the ICU may be engaging in a high-
cost behavior that does not improve patient outcomes.  
We could not directly determine whether an individual patient required ICU 
admission because our data source lacked acute clinical information such as patient 
vital signs and the results of diagnostic tests. Moreover, there are no clear 
standards for ICU admission. We sought, however, to characterize hospital-level 
patterns of ICU admission rather than determine the appropriateness of individual 
triage decisions and it is unlikely that patient case mix would account for the wide 
variation in admission rates among hospitals that we observed. Furthermore, the 
association of high ICU admission rates with less frequent use of ICU-level 
therapies suggests that higher admission rates were due to different admission 
thresholds rather than a more severe patient mix.  
The decision to triage to an ICU comes at a high cost to both the patient and 
the healthcare system. Hospitalization in the ICU has been shown to hold inherent 
risks for the patient, including increased risk of medication errors, delirium, 
hospital-acquired infection with multidrug resistant pathogens, and post-traumatic 
stress disorder.35-40 Furthermore, although ICU beds represent only 5-10% of total 
hospital capacity, ICU utilization accounts for as much as 20-35% of hospital cost.20 
The average daily cost to occupy an ICU bed is approximately $2,573.41-44 This 
amount does not include the opportunity cost of delaying or denying use of that bed 
to a patient with critical care needs because it is occupied by a patient who could be 
safely managed in another setting.  
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Despite these costs, there may be clinical reasons that such behavior persists 
among hospitals. We hypothesized that small hospitals may not have telemetry 
capabilities outside of the ICU and may admit patients with HF to the ICU for 
telemetry until myocardial infarction can be ruled out. Table 1, however, 
demonstrates that there is not a statistically significant difference in telemetry 
capability in beds outside of the ICU among hospitals in the top quartile compared 
with hospitals in other quartiles. 
Another clinical reason that differences in ICU triage exist may be related to 
the lack of guidelines that specify clinical criteria for ICU triage. The inconsistency 
in ICU resource utilization among hospitals underscores a need for improved HF 
triage guidelines for practitioners and adoption of HF risk-stratification models by 
hospitals.22 Triage decision-making, which the American Heart Association 
recognizes as having a “crucial bearing on resource utilization,” is not explicitly 
addressed in the most recent HF management guidelines.45 General critical care 
guidelines from the Society of Critical Care Medicine suggest that efficient ICU use 
requires that patients who do not immediately need intensive care treatments 
should be triaged to an ICU only if there is a high likelihood that they will 
subsequently need ICU-level therapies.46 Yet our findings add to other studies that 
have demonstrated that relatively healthy patients with HF may be frequently 
triaged to an ICU and often never receive critical care therapies associated with 
HF.24, 25, 47 In response to this trend, several validated risk-assessment models have 
been developed to aid in ICU triage decision-making, but have yet to be widely 
adopted by hospitals.47-49 These models have shown significant gains in improving 
the appropriateness of ICU triage both in the general medical population and 
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specifically for patients with HF. Our data imply that these efforts might lead to 
significant savings in resources.  
 In addition, hospital ICU utilization may be driven by economic 
considerations. Hospitals that frequently triage to the ICU may do so in an effort to 
recuperate the high fixed cost of maintaining an ICU bed in terms of staffing, 
equipment and space. If hospitals have ICU capacity beyond patient need for ICU 
beds and services, they have the opportunity to reduce fixed costs by eliminating or 
repurposing resources. Studies have shown, however, that hospitals have been 
slow to address excess fixed costs.50-52 This reluctance has significant implications 
for healthcare expenditures in the U.S., as more than 85% of hospital costs are 
fixed.  
Despite these drivers of ICU bed use, reports of individual hospitals in the 
U.S. championing ICU triage reform have shown that ICU utilization can be more 
rationally guided. Unnecessary ICU admissions can be reduced and the value of 
care provided increased with the commitment of hospital leadership to changing 
institutional policies and attitudes through locally derived data.23 For example, an 
18-hospital system implemented an ICU quality and efficiency improvement 
initiative that resulted in a reduction of the proportion of ICU admissions deemed 
“low-risk” from 42% to 22%. The hospitals identified inefficient triage practices by 
collecting data using risk scoring models that predict hospital mortality rates and 
comparing them with triage destinations. The hospitals used these data to assess 
ICU triage policies and win institution-wide acceptance of the need for better 
practices and accountability at all levels within the hospital. Their quality 
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management team rewrote hospital triage guidelines and moved from a subjective 
triage culture based almost totally on the discretion of the ICU director to a 
collaborative, data-driven approach involving emergency physicians, critical care 
physicians, nurse managers, and others. Institutional policy changed from a “next 
available bed” admission strategy, in which patients were admitted to beds based 
on availability, to one centered on patient needs. New policies received continual 
reinforcement by nurse and physician champions as well as top administrators. 
Thus, institution-level reforms to entrenched policy and culture may successfully 
improve hospital ICU triage practices. 
Our study should be interpreted with the following caveats. The hospital risk 
adjustment was limited to age, sex, race, and comorbidities because our data 
source lacked acute clinical information. However, risk adjustment for patients with 
HF based on those characteristics has been validated in other studies.53-55 Because 
of the lack of acute clinical data, we cannot comment on the appropriateness of ICU 
triage strategies. In addition, our dataset does not longitudinally track patient 
outcomes and we could not calculate long-term patient mortality, which could have 
been altered by ICU triage strategies even though in-hospital mortality was not. 
Moreover, although our cohort included more than 340 hospitals with diverse 
characteristics, all of them voluntarily participate in a consortium that gathers and 
shares data with the aim of improving hospital practices. This suggests that our 
cohort may be more sensitive to establishing efficient care practices than other 
hospitals, which may provide an underestimate of ICU triage rates nationally. 
Furthermore, our dataset does not contain information that would allow us to 
characterize ICUs to better understand the type of care offered, such as nursing 
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ratios or levels of ICU care. Finally, our dataset does not contain information 
regarding the provider type or physician reimbursement, which may explain some 
of the variation in clinical triage patterns.  
Identifying opportunities to improve the value of care provided to patients is 
especially important for hospitals and clinicians operating in an increasingly costly 
healthcare environment with greater resource constraints.12, 56, 57 Our findings 
demonstrate that a significant number of hospitals in the U.S. triage many more 
patients with HF to their ICUs relative to other hospitals, without achieving better 
in-hospital RSMRs. Given the high price of ICU admission, it is plausible that some 













1.6 Tables and Figures 
Figure 1. Hospital ICU admission rates. (Each data point shown represents a 
hospital.) 



















Number of beds     
1-200 125 (37) 48 (56) 69 (29)  
201 – 400 129 (38) 26 (30) 98 (40) <0.0001 
401 – 600 60 (17) 10 (12) 50 (21)  
>600 27 (8) 2 (2) 25 (10)  
ICU HF volume     
1 - 50 226 (66) 39 (45) 174 (72)  
51-200 104 (31) 36 (42) 68 (28)  
201 - 400 8 (2) 8 (9) 0 (0) <0.0001 
>400 3 (1) 3 (4) 0 (0)  
Geographic 
region 
   
 
Midwest 82 (24) 27 (31) 53 (22)  
Northeast 54 (16) 9 (11) 43 (18) 0.2 





West 65 (19) 18 (21) 43 (18)  
Population 
served 
   
 
Urban 267 (78) 63 (73) 197 (81) 0.1 
Rural 74 (22) 23 (27) 45 (19)  
Teaching status     
Non-teaching 247 (72) 71 (83) 165 (68) 0.01 




   
 
Yes 57 (17) 16 (19) 41 (17) 0.6 
No 284 (83) 70 (81) 201 (83)  
HF, heart failure; ICU, intensive care unit  
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Table 2. Proportion of ICU days receiving ICU-level therapy. 
 
Therapy  
Usage of therapy 
 (Proportion of bed-days) 
P-value 
High ICU admissions  
(N=31,066) 
Low ICU admissions 
(N=28,643) 
Mechanical ventilation 6 15 <0.0001 
NPPV 8 19 <0.0001 
Vasopressors and/or inotropes 9 16 <0.0001 
Vasodilators 6 12 <0.0001 
Pulmonary artery catheter 0.7 0.5 0.04 
None of these interventions* 74 49 <0.0001 
*No intervention includes mechanical ventilation, NPPV, vasopressors and/or inotropes, 
vasodilators, pulmonary artery catheter, dialysis, and intra-aortic balloon pump  





Table 3. Proportion of patients receiving ICU-level therapy. 
 
Therapy 
Usage of therapy 
(Proportion of patients receiving therapy) 
P-value 
High ICU admissions  
(N=8,830) 
Low ICU admissions 
(N=10,339) 
Mechanical ventilation 7 14 <0.0001 
NPPV 14 31 <0.0001 
Dialysis 0.01 0.10 0.01 
Vasopressors and/or inotropes 9 18 <0.0001 
Vasodilators 16 25 <0.0001 
Intra-aortic balloon pump 0.2 0.5 0.0016 
Pulmonary artery catheter 1 1 0.1 






Table 4. Patient mortality. 




In-hospital mortality for heart 
failure patients triaged to ICU 









High ICU admission 
group 
86 3.4 (3.0, 3.9) 
0.2† 
Low ICU admission 
group 
242 3.5 (3.0, 4.2) 
*Includes entire patient cohort (ICU and non-ICU) 
†Calculated using a 2-sided Wilcoxon Rank Sum test 









Supplemental Table 1. Selected comorbidities. 
Valvular disease 
Pulmonary circulation disease 
Peripheral vascular disease 
Paralysis 
Other neurological disorders 
Chronic pulmonary disease 
Diabetes without chronic complications 




Acquired immune deficiency syndrome 
Lymphoma 
Metastatic cancer 
Solid tumor without metastasis 






Fluid and electrolyte disorders 







Disorders of lipid metabolism 
Coronary atherosclerosis and other heart disease 
Acute myocardial infarction 
Peripheral and visceral atherosclerosis 
Aortic, peripheral and visceral artery aneurysms 
Aortic and peripheral arterial embolism or thrombosis 

















































Number of beds      
1-200 125 (37) 48 (56) 26 (31) 28 (33) 23 (27) 
201 – 400 129 (38) 26 (30) 37 (44) 32 (38) 34 (40) 
401 – 600 60 (17) 10 (12) 14 (17) 16 (18) 20 (23) 
>600 27 (8) 2 (2) 7 (8) 9 (11) 9 (10) 
ICU HF volume      
1 - 50 226 (66) 39 (45) 40 (48) 64 (75) 83 (97) 
51-200 104 (31) 36 (42) 44 (52) 21 (25) 3 (3) 
201 - 400 8 (2) 8 (9) 0 0 0 
>400 3 (1) 3 (4) 0 0 0 
Geographic region      
Midwest 82 (24) 27 (31) 18 (21) 22 (26) 15 (17) 
Northeast 54 (16) 9 (11) 12 (14) 16 (19) 17 (20) 
South 140 (41) 32 (37) 43 (51) 33 (39) 32 (37) 
West 65 (19) 18 (21) 11 (14) 14 (16) 22 (26) 
Population served      
Urban 267 (78) 63 (73) 70 (83) 70 (82) 64 (74) 
Rural 74 (22) 23 (27) 14 (17) 15 (18) 22 (26) 
Teaching status      
Non-teaching 247 (72) 71 (83) 59 (70) 62 (73) 55 (64) 
Teaching 94 (28) 15 (17) 25 (30) 23 (27) 31 (36) 
Telemetry available 
outside of ICU 



























Yes 57 (17) 17 (20) 18 (21) 12 (14) 13 (15) 
No 284 (83) 69 (80) 66 (79) 73 (86) 73 (85) 
HF, heart failure; ICU, intensive care unit   
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Supplemental Table 3. Proportion of ICU days receiving ICU-level therapy. 
Therapy  
Usage of therapy 












Mechanical ventilation 6 15 14 19 <0.0001 
NPPV 8 17 22 23 <0.0001 
Vasopressors and/or 
inotropes 
9 15 16 19 <0.0001 
Vasodilators 6 12 13 13 <0.0001 
Pulmonary artery 
catheter 
0.7 0.4 0.6 0.7 0.02 
None of these 
interventions* 
74 52 47 42 <0.0001 
*No intervention includes mechanical ventilation, NPPV, vasopressors and/or inotropes, 
vasodilators, pulmonary artery catheter, dialysis, and intra-aortic balloon pump  











Supplemental Table 4. Proportion of patients receiving ICU-level therapy. 
Therapy 
Usage of therapy 












Mechanical ventilation 7 15 13 16 <0.0001 
NPPV 14 28 33 36 <0.0001 
Dialysis 0.01 0.08 0.03 0.30 0.0006 
Vasopressors and/or 
inotropes 
9 16 17 22 <0.0001 
Vasodilators 16 25 25 25 <0.0001 
Intra-aortic balloon pump 0.2 0.3 0.4 1 <0.0001 
Pulmonary artery catheter 1 1 2 2 0.08 















Supplemental Table 5. Patient mortality. 




In-hospital mortality for heart 
failure patients triaged to ICU 
Top Quartile 8,830 4% 
<0.0001 
Quartile 3 5,273 7% 
Quartile 2 3,383 8% 
Bottom Quartile 1,683 11% 
Risk-standardized in-hospital 
mortality* 
Top Quartile 86 3.4 (3.0, 3.9) 
0.41 
Quartile 3 84 3.3 (3.1, 4.2) 
Quartile 2 85 3.4 (3.0, 4.3) 
Bottom Quartile 73 3.6 (3.2, 4.1) 
*Includes entire patient cohort (ICU and non-ICU) 
†Calculated using a 2-sided Kruskal-Wallis test 


































Hospital patterns of myocardial imaging and their association with downstream 



















Background. Once acute myocardial infarction (AMI) has been ruled out among 
patients presenting to the hospital with possible cardiac ischemia, current 
guidelines allow substantial discretion in the use of cardiac imaging in the initial 
evaluation. Despite the cost implications, few studies have compared how the use 
of these modalities varies among hospitals and their implications on downstream 
testing, interventions, and patient outcomes.   
Methods. Using the 2010 Premier Perspective® database, we defined patients 
suspected of myocardial ischemia on their initial evaluation as those seen in the 
emergency department, in observation status, or during inpatient hospitalization, 
who received at least one cardiac biomarker test ordered on day 0 or 1 of their 
hospital visit. We selected patients with a principal discharge codes consistent with 
myocardial ischemia and specifically excluded AMI. The primary outcome was the 
percentage of patients at each hospital who received myocardial imaging designed 
to evaluate for ischemia, including stress nuclear myocardial perfusion imaging 
(MPI), stress echocardiography, cardiac positron emission tomography, cardiac 
magnetic resonance imaging, and cardiac computed tomography with coronary 
angiography with or without calcium scoring. We compared hospitals above the 
median rate of imaging (high imaging) with hospitals below the median (low 
imaging) using Chi-square tests. We used hierarchical logistic regressions to 
identify predictors of imaging use as well as interclass correlation coefficients (ICC).    
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Results. We identified 549,078 patients at 224 hospitals. The median hospital 
imaging rate was 19.8% of patients (interquartile range 10.9% to 27.7%; range 
0.2% to 55.7%). High imaging hospitals were associated with higher rates of 
catheterization for coronary angiogram (4.1% versus 1.7%) and more 
revascularization procedures (1.5% versus 0.7%). Readmission rates to the same 
hospital for AMI within the same or subsequent month were not different (0.3% 
versus 0.3%). Almost 23% of variation in imaging use among hospitals was 
attributable to individual hospital-level factors. 
Conclusions. Substantial variation exists among hospitals in their use of 
myocardial imaging in the initial work-up of patients with suspected ischemia that is 
not AMI and much of this variation is explained by hospital-level factors. Despite 
much higher rates of imaging and associated higher rates of downstream invasive 
testing, high imaging hospitals perform only slightly more revascularization 















Chest pain is the second most common cause of emergency department 
visits and accounts for over $3.7 billion in hospital costs.58, 59 The vast majority of 
patients presenting with chest pain do not have acute myocardial infarction (AMI).60 
Clinicians have many options during the initial evaluation of these patients in 
seeking to determine the patient’s risk for a cardiovascular event, and the 
information that they glean often guide decisions about hospitalization as well as 
the need for further testing and treatment.  
There are few studies that have compared the hospitals’ approach to the 
evaluation of patients presenting acutely for ischemic work-up who do not have 
AMI. In particular, physicians face a decision about the use of imaging in stress 
testing. Imaging imposes significant healthcare costs and, except for 
echocardiography, radiation exposure.61 These considerations must be weighed 
against the possibility that imaging increases the sensitivity and specificity of stress 
testing, leading to better decisions and possibly better patient outcomes.62 
Unfortunately, clinical guidelines do not provide strong recommendations about 
which patients should undergo specific testing strategies, leaving considerable 
discretion to the practitioner.6, 63 Without well established guidelines, hospitals have 
developed several different diagnostic approaches to these patients with some 
creating units dedicated to assessing suspected myocardial ischemia with either 
mandatory or optional myocardial imaging.62, 64-67  
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We currently have little information about how hospitals vary in their 
patterns of myocardial imaging use among patients being evaluated for ischemia 
who do not have AMI. The implications of variation in myocardial imaging use 
among hospitals may be far-reaching as previous patient-level studies have shown 
that frequent use of myocardial imaging is associated with a greater likelihood to 
perform more invasive and expensive downstream tests, such as catheterization for 
coronary angiography, without clear improvements in outcomes.68, 69 Evidence of 
marked variation in practice that is associated with the hospital more than the 
patient would highlight an urgent need to clarify the marginal benefit of more 
expensive strategies and those that expose patients to radiation.  
Our aim is to describe variation among hospitals in the use of myocardial 
imaging in patients who initially were evaluated for myocardial ischemia but who 
did not have AMI. We sought to determine whether the hospital’s use of myocardial 
imaging was associated with patterns of downstream resource utilization, including 
inpatient hospitalization and catheterization for coronary angiography. Furthermore, 
we sought to determine if hospitals that frequently used myocardial imaging in their 
initial assessment subsequently performed revascularization procedures such as 
percutaneous coronary intervention (PCI) and coronary artery bypass grafting 
(CABG) at a substantially higher rate. Finally, we aimed to determine whether more 
frequent use of myocardial imaging among hospitals was associated with fewer 






Data Source  
We conducted a cross-sectional study of data using Perspective®, a 
voluntary, fee-supported database developed by Premier, Inc. for measuring quality 
and healthcare utilization. Premier is a private consortium of hospitals that pools 
finances and a subset of clinical data from hundreds of U.S. hospitals into a 
common database.26 From 2005 to 2010, Perspective® accumulated data from over 
130 million hospital discharges. These inpatient discharges represent about 20% of 
all acute care inpatient hospitalizations nationwide. In addition to the information 
available in the standard hospital discharge file, Perspective® contains a date-
stamped log of all billed items at the individual patient level including medications 
and laboratory, diagnostic, and therapeutic services, as well as limited clinical data 
about each patient. For this study, patient data were de-identified in accordance 
with the Health Insurance Portability and Accountability Act and a random hospital 
identifier assigned by Premier was used to identify the hospitals. The Yale 
University Human Investigation Committee exempted this study protocol because it 
is not considered Human Subjects Research as defined by the Office of Human 
Research Protections. 
Study Cohort 
We included hospital visits that occurred during 2010, including those 
restricted to only the emergency department, those in which the patient stayed in a 
bed labeled with observation status, and those in which a patient was admitted to 
an inpatient bed. In order to include patients in whom cardiac ischemia was being 
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considered as a primary diagnosis, we required that patients must have received at 
least one cardiac biomarker test to assess for myocardial necrosis, which was 
defined as either a serum cardiac troponin or creatine kinase-MB. Cardiac 
biomarkers had to be ordered on day 0 or day 1 of the patient’s visit.  
In addition, patients must have had one of the International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) principal discharge 
diagnoses listed in Supplemental Table 1. These codes were selected based upon a 
review by three authors (KS, AV, KD) to determine whether they met any of the 
following criteria: (1) represents a common cause of chest discomfort; (2) 
represents a symptom or sign that can be associated with chest discomfort; or (3) 
represents a diagnosis that is often co-morbid with coronary artery disease. 
Patients with a primary discharge diagnosis of AMI were specifically excluded 
because well-established guidelines exist for myocardial testing in these patients.  
In addition, diagnoses in which an acute, emergent non-cardiac disease may 
have warranted cardiac biomarker testing but not myocardial imaging were 
excluded because we sought to compare hospital myocardial imaging use in 
situations where it was likely to be realistically considered as an option in the 
patient’s management. These excluded diagnoses were aortic dissection, pulmonary 
embolism, and gastrointestinal ulcers with hemorrhage or perforation. Hospital 
visits were excluded if patients were younger than 35 years of age at the time of 
admission, assigned a pediatrician as the attending of record, transferred in from 
another hospital, transferred out to another hospital, or received cardiac surgery 
during their stay, with the exception of coronary artery bypass grafting (CABG). 
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Excluded cardiac surgeries were valvular surgeries, vascular surgeries, ventricular 
assist device placement, and heart transplantation in which biomarkers may have 
been ordered for pre or peri-operative evaluation. 
Only hospitals that participated in Premier’s research program in 2010 and 
performed at least 5 revascularization procedures were considered for inclusion in 
the study. We set these minimum requirements in order to reliably assure that we 
were comparing hospitals capable of performing catheterization for coronary 
angiography and revascularization procedures. Revascularization procedures were 
defined as percutaneous coronary interventions (PCI) or CABG.  
Outcomes 
The primary outcome for each hospital was the proportion of its patients that 
received myocardial imaging testing out of all patients meeting inclusion criteria at 
the hospital. Myocardial imaging tests were defined as stress nuclear myocardial 
perfusion imaging (MPI), stress echocardiography, cardiac positron emission 
tomography (CPET), cardiac magnetic resonance imaging (MRI), and cardiac 
computed tomography with coronary angiography (CTCA) with or without calcium 
scoring.  
In order to determine the association of imaging use with downstream 
resource utilization, we calculated for each hospital the proportion of patients 
meeting inclusion criteria who: (1) were discharged from an inpatient bed; (2) 
received catheterization for coronary angiogram downstream of imaging; and, (3) 
received revascularization (either PCI or CABG).  
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The hospital visit during which the patient received the cardiac biomarker 
test as well as a primary discharge diagnosis that met the inclusion criteria was 
defined as the index hospital visit. Myocardial imaging tests, catheterizations for 
coronary angiography, and revascularization procedures were counted if they 
occurred within the same month or in the month following the index hospital visit. 
Finally, we calculated readmissions for AMI as the proportion of patients who 
returned to the same hospital with a principal discharge diagnosis of AMI (410.x) 
within the same month or month following the index hospital visit. 
Statistical Analysis 
Hospitals were divided into two groups based on the proportion of patients 
who received myocardial imaging tests. In order to make the most conservative 
comparison, we compared hospitals above the median rate of myocardial imaging 
(high imaging hospitals) with hospital below the median rate of myocardial imaging 
(low imaging hospitals). Hospital characteristics of the high imaging hospitals were 
compared with the characteristics of the low imaging hospitals using chi-square 
tests to assess statistical differences. We also assessed the use of specific types of 
imaging modalities among the hospitals and compared high imaging hospitals with 
low imaging hospitals. Furthermore, we compared the two groups of hospitals to 
determine the association of imaging with downstream resource utilization by 
calculating the number of patients in the cohort who: (1) were admitted to an 
inpatient bed during their index hospital encounter; (2) received catheterization for 
coronary angiogram after having received imaging; and, (3) received a 
revascularization procedure. In order to determine the association of imaging with 
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outcomes, we compared high versus low imaging hospitals in terms of the 
proportion of patients in the cohort who were readmitted with AMI to the same 
hospital as their index encounter during the same month or month following the 
index hospital visit. A p-value <0.05 was considered statistically significant in all 
cases. Continuous variables are reported with medians and interquartile ranges 
(IQR). Finally, we performed a sensitivity analysis by dividing the hospitals into 
quartiles based on the proportion of patients who received myocardial imaging test 
and repeated the above analyses comparing quartiles for differences in hospital 
characteristics, downstream angiogram use, revascularization, and readmissions for 
AMI. 
In addition, we sought to understand the degree to which patient case-mix 
and hospital factors explained the variation. To do this, we fit three hierarchical 
logistic regression models.  In the first model, we fit an empty model with only a 
hospital random intercept to determine whether any hospital-level variation existed.  
In the second model, we incorporated patient characteristics, including age and 
sex, in order to investigate the extent with which hospital differences in myocardial 
imaging were explained by the patient mix of the hospitals.  Finally, in the third 
model we incorporated hospital characteristics to see how much of the variation 
could be explained by known hospital characteristics.  For each of the models, we 
calculated the hospital-level variance and reported a C-statistic as a measure of 
model discrimination. We then derived the interclass correlation coefficient (ICC) to 
measure the proportion of variance attributable to the between hospital variation, 




Myocardial imaging rates and hospital characteristics 
Our cohort included 549,078 patients treated at 224 hospitals from across 
the U.S. The median hospital bed size was 360 (IQR: 250, 462). Hospitals tended 
to be located in the South (41%), serve an urban population (88%), and identify as 
non-teaching (66%). 
Figure 1 demonstrates the proportion of patients at each hospital who 
received myocardial imaging tests. The range of myocardial imaging rates for 
hospitals was from 0.2% to 55.7% (median 19.8%, IQR: 10.9, 27.7%). High 
imaging hospitals performed imaging in 29.1% of their patients, on average, 
compared with 10.9% of patients at low imaging hospitals (p<0.0001).  
Hospitals with myocardial imaging rates above the median rate of imaging 
and hospitals below the median tended to have similar characteristics in terms of 
bed size (p=0.08), having beds with observation status (p=0.87), population 
served (p=0.84), and teaching status (p=0.16; Table 1). We observed that 
hospitals above the median were more likely to be located in the Midwest and 
Northeast (p<0.0001; Table 1).  
Hospitals tended to use MPI and stress echocardiography most commonly 
when performing myocardial imaging (Figure 2). There were small, but statistically 
significant differences when comparing high imaging hospitals with low imaging 
hospitals in terms of the rates at which they used specific modalities when 
performing myocardial imaging (Table 2). 
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Catheterization for Coronary Angiogram  
The range of hospital angiogram rates was from 0.0% to 16.9% (median 
2.5%, IQR: 1.4, 4.1%). Among visits at high imaging hospitals, 4.1% received 
catheterization for coronary angiogram downstream of imaging compared with 
1.7% at low imaging hospitals (p<0.0001; Table 3).  
Revascularization procedures 
The range of revascularization procedures performed was from 0.0% to 9.5% 
(median 0.8%, IQR: 0.4, 1.4%). Among visits at high imaging hospitals, slightly 
more revascularization procedures were performed compared with low imaging 
hospitals (1.5% versus 0.7%, p<0.0001; Table 3).  
Readmission with AMI  
High imaging hospitals had a similar proportion of patients who were 
readmitted for AMI within the same or subsequent month as the index hospital 
visit, compared with low imaging hospitals (0.3% versus 0.3%, p=0.3134; Table 
3).  
Sensitivity Analysis 
 The above comparisons were repeated for quartiles of hospitals stratified by 
myocardial imaging rates as opposed to comparing hospitals as above or below the 
median rate.  In terms of hospital characteristics, only hospital geographic location 
seems related to rates of myocardial imaging when comparing each of the four 
quartiles of hospitals (Supplemental Table 2). Quartiles of hospitals with higher 
rates of myocardial imaging tended to have higher catheterization rates for 
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coronary angiogram, similar rates of revascularization procedures overall, and the 
same readmission rates for AMI (Supplemental Table 3). 
Institutional effects on myocardial imaging utilization 
 The interclass correlation coefficients (ICCs) (95% confidence interval) for 
the unadjusted model (empty model), the model adjusted for patients’ age and sex, 
and the model further adjusted for hospital characteristics are 23.18 (19.54- 
26.52), 23.27 (19.61-26.61) , and 16.08 (8.64-22.40), respectively (Table 4).  This 
demonstrates that about 23% of the variation in myocardial imaging rates is 
attributable to between hospital variation, and this variation is not affected by 
patient-mix.  When known hospital characteristics are included, the ICC drops to 
16%.  The median odds ratio was 2.6 for the empty model and the age/sex-
adjusted model, and 2.2 for the model with hospital characteristics.  These results 
signify that a randomly selected patient receiving myocardial imaging at one 
hospital would have around 2-fold higher odds of receiving an imaging test than an 










Substantial hospital-level variation exists in the use of myocardial imaging in 
patients deemed not to have an AMI who are undergoing further work-up for 
coronary artery disease. Greater use of non-invasive myocardial imaging was 
associated with increased use of downstream invasive imaging with catheterization 
for coronary angiography. If a hospital more frequently uses imaging and 
subsequent coronary angiograms, it might be expected that the hospital will use 
that information to alter the patient’s management in terms of revascularization 
interventions or to achieve better patient outcomes, given the expense of these 
tests and the patient’s exposure to harmful radiation. Yet hospitals that more 
frequently engaged in testing did not have substantially higher rates of 
revascularization interventions.  Furthermore, high imaging hospitals did not 
achieve lower rates of same hospital readmission with AMI. Thus, our study 
suggests that frequent use of myocardial imaging at a group of U.S. hospitals led to 
greater use of invasive downstream diagnostic tests without substantially affecting 
the use of therapeutic interventions or achieving better short-term outcomes.  
The results of our study extend the prior literature demonstrating variation in 
the use of expensive diagnostic modalities in the evaluation of common acute 
clinical presentations.70-72 Prior studies have shown that variation has particularly 
occurred in clinical scenarios in which guidelines are not well established, including 
neuroimaging in the evaluation of dizziness, headache, trauma and epilepsy. For 
subgroups of patients in which guidelines are more well-established, such as in the 
neuroimaging of children, variation was considerably less. In comparison, clinical 
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guidelines do not clearly identify which patients who should receive cardiac 
imaging, out of the clinically heterogeneous group presenting with suspected 
myocardial ischemia.  
Moreover, our findings are similar to other studies which have raised the 
question of whether increased use of an expensive diagnostic modality translated 
into improved patient outcomes. For example, despite high rates of imaging, such 
as head CT in patients presenting with symptoms of stroke or chest CT in patients 
presenting with chest symptoms, the rates at which stroke and pulmonary 
embolism have been diagnosed have not changed.70, 72 One potential explanation 
for unchanged outcomes despite higher rates of myocardial imaging is that 
hospitals that use imaging more frequently are doing so in patients where the 
benefit is not clear. Again, without strong evidence upon which to develop clear 
recommendations in the guidelines it may not be readily apparent to clinicians 
which patients are likely to benefit from imaging. 
Previous single center studies have shown that, regardless of pre-test 
probability, patients frequently received non-invasive myocardial imaging.73 The 
trends that emerged in our study suggest similar findings as hospitals that more 
frequently used imaging performed revascularization procedures in only a slightly 
larger proportion of their patients. Thus, the rates at which high imaging hospitals 
found lesions on which they performed revascularization were lower compared with 
low imaging hospitals. In addition, studies have shown that frequent use of cardiac 
imaging is associated with a greater number of findings that are false positives or 
classified as having indeterminate significance.74 These categories of findings can 
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drive higher rates of coronary catheterization with angiogram for lesions that 
ultimately do not meet criteria for revascularization.  
In an attempt to understand what may have driven the variation in imaging 
practices, a hierarchical logistical regression analysis showed that differences in 
patient case-mix between hospitals did not explain the majority of the variation, 
while hospital factors, such as geographic location, did explain a significant 
proportion of the variation. Our study adds to other studies on cardiac imaging use 
by demonstrating that the likelihood that a patient receives a given testing strategy 
in their work-up depends largely upon what hospital the patient receives his or her 
care.67, 73The finding that the geographic location of the hospital is associated with 
differences in the use of imaging tests is consistent with studies on imaging use in 
the outpatient setting, but further work is necessary to enrich our understanding of 
what aspects of hospital practice are driving the use of imaging and why.67 For 
example, prior studies suggest that hospitals employ different protocols in the 
work-up of patients with suspected ischemia, with some reflexively ordering 
myocardial imaging as a rule out for coronary disease.64-66 In addition, some 
hospitals may respond more to financial incentives to order imaging tests compared 
with others. Studies, for example, have demonstrated that if a physician practice 
purchases its imaging equipment, utilization and spending increase substantially.75 
It is plausible that hospitals may experience similar motivations once investing in 
expensive imaging equipment.  
Our study, as well as those mentioned above, suggest that nationally 
endorsed quality measures on imaging use could have a positive impact by 
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targeting imaging to patients who are more likely to benefit from it. In recent 
years, the American College of Cardiology has released consensus standards on the 
appropriate use criteria (AUC) for stress cardiac radionuclide imaging and 
echocardiography in patients presenting with suspected ischemia.76-78 The AUC are 
designed to reduce wasteful utilization by targeting imaging to patients with higher 
pretest probability for occlusive coronary artery disease. The AUC continue to 
evolve as the threshold for appropriate testing continues to rise.79, 80 Scenarios in 
which imaging would not be considered appropriate and which may have occurred 
in the hospitals in this study include patients presenting with acute chest pain who 
have low pre-test probability of coronary disease and are able to exercise.76, 77 
Another example scenario in which imaging would be inappropriate includes 
patients with stable symptoms and known coronary disease who have had a stress 
test within the prior two years. While we could not directly determine the 
appropriateness of imaging use in any given patient, we fail to produce evidence 
that hospitals that are performing more imaging are, at the margin, providing 
greater benefits to the patient. Future efforts should directly study the 
appropriateness of imaging use in patients. In the future, the AUC may provide a 
basis for monitoring the appropriateness of hospital testing practices and could be 
used to incentivize more efficient use if hospitals are held accountable or rewarded 
based on their record.  
The cohort of hospitals in this study was diverse, but there may be some 
questions about the generalizability of our sample. In terms of size, rural or urban 
setting, geographic region, and teaching status, our cohort included a full spectrum 
of the types of hospitals in the U.S. In addition, the cohort of patients in this study 
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is highly specific for individuals being evaluated for cardiac ischemia. Because our 
database indicates whether a cardiac troponin test was ordered for a patient, we 
were able to avoid the selection bias and misclassification that results from previous 
studies that attempted to identify patterns of care for patients with chest pain 
based solely on discharge diagnosis. In fact, we found that among patients who 
received a troponin test within the first day of their hospital encounter, over 3,600 
primary discharge diagnosis codes were used and only 25% of these patients were 
coded with chest pain diagnoses. The remaining codes were included in our study if 
they represented common causes of chest pain, symptoms commonly associated 
with chest pain, and comorbidities that may cause concern for occlusive coronary 
disease.  
Our study has several limitations. First, we were not able to track whether a 
hospital referred a patient for myocardial imaging to a different hospital. However, 
it is unlikely that hospitals with the capability to perform myocardial imaging (which 
all of our hospitals had) would refer patients to another hospital for an imaging 
study. Moreover, patients may seek care at multiple hospitals and we were not able 
to capture downstream testing and revascularization if it occurred at a hospital 
different from where the patient had his or her index encounter. In addition, 
although our cohort included more than 220 hospitals with diverse characteristics, 
all of them voluntarily participate in a consortium that gathers and shares data with 
the aim of improving hospital practices. This suggests that our cohort may be more 
sensitive to establishing efficient care practices than other hospitals, which may 
provide an underestimate of imaging rates nationally. In addition, our 
administrative database does not contain acute clinical data, patient socioeconomic 
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information, or hospital or community level characteristics regarding provider 
access, which may influence hospital practice patterns. Finally, we could only 
capture readmissions for AMI if the patient was readmitted to the same hospital at 
which they received their initial evaluation. Though this may mean that readmission 
rates were in fact higher than what we report, it is unlikely that the relative 
readmission rates when comparing high versus low imaging hospitals would be any 
different 
In a healthcare system facing greater resource constraints, it is increasingly 
important to identify opportunities to reduce healthcare utilization that is not 
associated with improved patient outcomes. With over 7.2 million emergency 
department visits annually in which chest pain is the primary diagnosis, the cost 
implications of myocardial testing practices are significant.81 We identified 
substantial variation in the use of myocardial imaging in patients presenting for 
ischemia work-up, but much smaller differences in revascularization intervention 
rates and no difference in readmission outcomes. An important determinant of 
whether these expensive tests were used was the hospital at which the patient 








2.6 Tables and Figures 














































Number of beds 
  
0.08 
1-200 15.2 (17) 14.3 (16) 
 201 – 400 53.6 (60) 38.4 (43) 
 401 – 600 22.3 (25) 31.3 (35) 
 >600 8.9 (10) 16.1 (18) 
 Hospital has patients with 
observation status (%)   0.87 
Yes 78.6 (88) 79.5 (89)  




Midwest 12.5 (14) 33.9 (38) 
 Northeast 12.5 (14) 15.2 (17) 
 South 42.9 (48) 39.3 (44) 
 West 32.1 (36) 11.6 (13) 
 Population served 
  
0.84 
Urban 88.4 (99) 87.5 (98) 
 Rural 11.6 (13) 12.5 (14) 
 Teaching status 
  
0.16 
Non-teaching 70.5 (79) 61.6 (69) 

















































Hospital Ranked by % Receiving Myocardial Imaging 




















Medicine 80.4 85.1 79 <0.0001 
Echocardiogram 16.6 13.5 17.5 
 Coronary CT Angiogram 
with or without Calcium 
Score 1.2 0.8 1.3 
 Cardiac MRI 0.1 <0.1 0.1 
 PET Scan <0.1 0.2 0 
 More than one type 1.7 0.5 2.2 





























Imaging (%) 10.9 29.1 
 Admission (%) 
        Discharged from ED or observation bed 34.5 38.9 <.0001 
     Discharged from inpatient bed 65.5 61.2 
 Received coronary angiogram (%) 1.7 4.1 <.0001 
Received revascularization (%) 0.7 1.5 <.0001 






































Random effects hospital level 







Interclass correlations ICC, % 







MOR† 2.58 2.58 2.13 
*    
  










Supplemental Table 1. ICD-9CM codes selected for inclusion. 
 Common causes of 
chest pain 
          Coronary atherosclerosis 
 Coxsackie viral disease 
  Acute pericarditis 
  Acute myocarditis 
  Anxiety states 
  Pleurisy 
  Tietze’s disease 
  Mediastinitis 
  Esophagitis (includes GERD) 
            Acute Gastritis, acute duodenitis 
  Gastric and duodenal ulcer disease 
  Cholelithiasis, cholecystitis, 
choledocolithiasis 
  Spondylosis (cervical and thoracic) 
  Intervertebral disc disease (cervical and 
thoracic) 
            Rotator cuff and shoulder disease 
 Signs and symptoms 
of cardiac chest pain 
          Angina (decubitis, pectoris, prinzmetal) 
           Palpitations 
            Cardiac dysrhythmias 
            Abnormal heart sounds and murmurs 
  Nausea 
  Vomiting 
  Abdominal bloating 
  Abdominal pain 








 Disorders of lipid metabolism 
 Hypertension (essential and secondary) 
  Hypertensive heart and/or kidney disease 
  Peripheral artery atherosclerosis and renal 
artery atherosclerosis 
  Cardiomyopathies 
  Coronary atherosclerosis 
  Coxsackie viral disease 
  Acute pericarditis 
  Acute myocarditis 
  Anxiety states 





Supplemental Table 2.  Hospital characteristics by hospital imaging quartiles. 
 














1-200 12.5 17.9 14.3 14.3 
 
201 – 400 62.5 44.6 33.9 42.9 
 
401 – 600 14.3 30.4 32.1 30.4 
 









Yes 80.4 76.8 76.8 82.1  







Midwest 3.6 21.4 32.1 35.7 
 
Northeast 8.9 16.1 14.3 16.1 
 
South 46.4 39.3 41.1 37.5 
 








Urban 87.5 89.3 89.3 85.7 
 








Non-teaching 73.2 67.9 58.9 64.3 


























Imaging (%) 6.0 15.9 23.5 34.8 
 Admission (%)   
  
<0.0001 
     Discharged from ED or observation bed 67.9 63.0 62.3 60.0 
      Discharged from inpatient bed 32.1 37.0 37.8 40.0 
 Received coronary angiogram (%) 1.2 2.2 3.3 4.9 <0.0001 
Received revascularization (%) 0.5 0.9 1.2 1.9 <0.0001 
Readmission with AMI (%) 0.3 0.3 0.3 0.3 0.51 
 
  




 Our studies demonstrate two scenarios in which higher intensity 
patterns of hospital care are not associated with improved patient outcomes. 
In a healthcare system faced with increased resource constraints, it will be 
imperative to reduce expensive care patterns. Yet it is incumbent upon 
reformers to target not just any expensive care patterns, but particularly 
those that are not shown to be linked with better quality care for the patient. 
In each study, our findings suggest that a large subset of U.S. hospitals use 
expensive resources in a disproportionately higher percentage of patients as 
compared to other hospitals, but do not achieve improved mortality or 
readmission outcomes, respectively.  
 Moreover, our studies demonstrate that the hospital may be a useful 
entry-point for researchers, providers, payors, and policy makers to convene 
in order to reduce unnecessary healthcare utilization. In the second study, 
we performed an analysis that demonstrates that a significant proportion of 
the variation in myocardial imaging use was due to hospital-level factors and 
that patient-level factors account for very little of the observed differences in 
imaging rates. Bringing into focus the internal practices of the hospital—
clinically, financially, and managerially—may elucidate numerous 
opportunities to improve the efficiency of care and to reduce waste in our 
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